Figure 7. The Kaplan-Meier curve of stage 1 and 2 ovarian clear cell adenocarcinoma patients with or without Met amplification.
Patients with Met amplification had a significantly worse prognosis (p<0.05).
Patients with Met amplification had a significantly worse prognosis (p<0.05).